VSee Health, Inc. (NASDAQ:VSEE) Sees Significant Increase in Short Interest

VSee Health, Inc. (NASDAQ:VSEE) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 70,300 shares, a growth of 53.5% from the September 15th total of 45,800 shares. Currently, 1.2% of the shares of the stock are sold short. Based on an average daily volume of 470,900 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 470,900 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.2% of the shares of the stock are sold short.

Institutional Investors Weigh In On VSee Health

A number of hedge funds have recently added to or reduced their stakes in VSEE. HB Wealth Management LLC bought a new stake in VSee Health during the 1st quarter worth about $723,000. Osaic Holdings Inc. boosted its stake in shares of VSee Health by 197.5% in the 2nd quarter. Osaic Holdings Inc. now owns 45,170 shares of the company’s stock valued at $52,000 after purchasing an additional 29,985 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in shares of VSee Health in the 1st quarter valued at about $34,000. Institutional investors own 1.01% of the company’s stock.

VSee Health Price Performance

Shares of NASDAQ:VSEE opened at $0.95 on Wednesday. VSee Health has a 12 month low of $0.46 and a 12 month high of $3.54. The company’s 50-day moving average price is $0.69 and its two-hundred day moving average price is $1.01.

VSee Health (NASDAQ:VSEE) last issued its quarterly earnings data on Wednesday, October 15th. The company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.02). VSee Health had a negative return on equity of 146.51% and a negative net margin of 461.61%.The company had revenue of $3.39 million for the quarter, compared to the consensus estimate of $3.90 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of VSee Health in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.00.

About VSee Health

VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.